Fresenius Medical Care Launches 4008A Dialysis Machine in China

Fresenius Medical Care Launches 4008A™ Dialysis Machine in China
February 2, 2021 0 Comments

  Fresenius Medical Care Launches 4008A™ Dialysis Machine in China

    Enhancing dialysis service and accessibility to learn extra sufferers

Enterprise Wire

HANGZHOU, China -- September 19, 2019

Fresenius Medical Care, the world’s main supplier of dialysis merchandise and
providers, right this moment introduced the launch of its 4008A^TM dialysis machine in
China. The product is solely designed to include Fresenius Medical
Care’s high-quality requirements whereas lowering prices for well being care techniques,
assembly the wants in rising markets. With the launch of the 4008A^TM,
Fresenius Medical Care is aiming to deliver high quality life-sustaining dialysis
therapy to extra sufferers in China who're affected by end-stage renal
illness (ESRD).

This press launch options multimedia. View the complete launch right here:

Fresenius Medical Care proudly launched the 4008A dialysis machine in China
right this moment. (Picture: Enterprise Wire)

Fresenius Medical Care proudly launched the 4008A dialysis machine in China
right this moment. (Picture: Enterprise Wire)

ESRD is the stage in kidney illness when an individual's kidneys completely cease
working correctly. To remain alive, the affected person might want to bear long-term
dialysis or obtain a kidney transplant. At the moment greater than 600,000 sufferers
in China had entry to dialysis, however the estimated ESRD prevalence is way
greater. It's essential to be sure that more cost effective options are
out there for these sufferers in want of life-sustaining dialysis remedy.

Harry de Wit, Chief Government Officer of Fresenius Medical Care Asia-Pacific,
mentioned: “It is very important improve the accessibility to high quality dialysis
therapy in China, the place over 1.4 billion of persons are dwelling. We all know from
studies that sadly not all sufferers have entry to dialysis therapy
in China. To assist sort out this well being care problem, we're very proud to
introduce the 4008A^TM to China.”

Assembly the wants of sufferers in China

“It is very important improve the accessibility and affordability of dialysis in
major care, particularly within the rural areas in China,” Mr. Alan Chen,
Government Vice President of Fresenius Medical Care, Higher China mentioned. “As
the worldwide chief in dialysis therapies, Fresenius Medical Care is dedicated
to offering high-quality services and products to sufferers, serving to them to
lead fulfilling lives. Lately, the Chinese language Authorities has been encouraging
the attain of high quality medical assets to rural areas, with a purpose to promote
major healthcare in these areas. In view of the wants of Chinese language sufferers,
Fresenius Medical Care is devoted to contributing to the ‘Wholesome China
2030’ initiative of the Chinese language authorities, of which the event of
skilled dialysis facilities is among the initiatives. With our experience,
innovation and data we're in a position to assist China’s overarching imaginative and prescient and
present hope to sufferers and their households.”

A milestone of innovation in China

The 4008A^TM dialysis machine is a serious innovation and a joined final result of
the useful collaboration between the Fresenius Medical Care China Design
Heart in Shanghai and the corporate’s Analysis and Growth groups in

“With the native insights and data from our R&D staff in China, the
4008A^TM with its excessive stage of security and dealing with requirements, together with
important cleansing features and battery back-up will profit the huge numbers
of dialysis sufferers in China. The machine is designed to be strong and simply
dealt with, making it excellent for distant areas,” Dr. Olaf Schermeier, Chief
Government Officer for World Analysis and Growth at Fresenius Medical
Care, mentioned. “Sooner or later, we'll proceed to innovate in China to cater for
the wants of growing markets, in order that extra sufferers within the area can
profit from high-quality dialysis therapy.”

Along with the launch of the 4008A^TM, Fresenius Medical Care additionally
introduced an initiative devoted to offering care and training to
nephrologists, nursing employees and sufferers in areas with insufficient well being care
assets. With the hope of bringing sufferers a brighter future with a excessive
high quality of life, the corporate will conduct analysis, academic coaching and
public lectures to convey kidney illness info and therapy administration
ideas to Chinese language healthcare professionals and sufferers in rural areas in
order to equip them with data and care with a purpose to deliver constructive modifications
to their lives.



Fresenius Medical Care is the world's main supplier of merchandise and
providers for people with renal ailments of which round 3.4 million
sufferers worldwide often bear dialysis therapy. Via its community
of three,996 dialysis clinics, Fresenius Medical Care supplies dialysis remedies
for 339,550 sufferers across the globe. Fresenius Medical Care can also be the
main supplier of dialysis merchandise equivalent to dialysis machines or dialyzers.
Together with the core enterprise, the corporate focuses on increasing the vary of
associated medical providers within the subject of Care Coordination. Fresenius Medical
Care is listed on the Frankfurt Inventory Alternate (FME) and on the New York Inventory
Alternate (FMS).


This launch accommodates forward-looking statements which can be topic to numerous
dangers and uncertainties. Precise outcomes might differ materially from these
described in these forward-looking statements because of numerous elements,
together with, however not restricted to, modifications in enterprise, financial and aggressive
circumstances, authorized modifications, regulatory approvals, outcomes of scientific research,
overseas trade fee fluctuations, uncertainties in litigation or
investigative proceedings, and the provision of financing. These and different
dangers and uncertainties are detailed in Fresenius Medical Care AG & Co. KGaA's
studies filed with the U.S. Securities and Alternate Fee. Fresenius
Medical Care AG & Co. KGaA doesn't undertake any duty to replace the
forward-looking statements on this launch.

View supply model on


Dr Alexandra Villar
Senior Director
Company Communications and Branding
[email protected]

Leave a Reply

Your email address will not be published. Required fields are marked *